Royal Bank of Canada’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.2M Buy
40,649
+13,551
+50% +$755K ﹤0.01% 3020
2025
Q4
$1.52M Buy
27,098
+480
+2% +$24.9K ﹤0.01% 3333
2025
Q3
$1.28M Sell
26,618
-6
-0% -$268 ﹤0.01% 3777
2025
Q2
$1.08M Sell
26,624
-754
-3% -$30.3K ﹤0.01% 3828
2025
Q1
$1.2M Sell
27,378
-23,726
-46% -$1.05M ﹤0.01% 3330
2024
Q4
$2.2M Buy
51,104
+26,173
+105% +$1.19M ﹤0.01% 2958
2024
Q3
$1.11M Sell
24,931
-12,937
-34% -$554K ﹤0.01% 3462
2024
Q2
$1.51M Buy
37,868
+8,456
+29% +$343K ﹤0.01% 3124
2024
Q1
$1.27M Buy
29,412
+3,003
+11% +$129K ﹤0.01% 3266
2023
Q4
$1.1M Sell
26,409
-22,954
-47% -$870K ﹤0.01% 3593
2023
Q3
$1.96M Buy
49,363
+13,038
+36% +$552K ﹤0.01% 2868
2023
Q2
$1.49M Sell
36,325
-11,950
-25% -$493K ﹤0.01% 3069
2023
Q1
$1.98M Buy
48,275
+10,259
+27% +$431K ﹤0.01% 2806
2022
Q4
$1.56M Sell
38,016
-6,653
-15% -$277K ﹤0.01% 3129
2022
Q3
$1.79M Buy
44,669
+1,887
+4% +$80.7K ﹤0.01% 2941
2022
Q2
$1.8M Sell
42,782
-19,097
-31% -$801K ﹤0.01% 2991
2022
Q1
$2.8M Sell
61,879
-1,419
-2% -$62.4K ﹤0.01% 2752
2021
Q4
$2.92M Buy
63,298
+12,953
+26% +$614K ﹤0.01% 2831
2021
Q3
$2.39M Buy
50,345
+25,080
+99% +$1.25M ﹤0.01% 2930
2021
Q2
$1.31M Sell
25,265
-6,539
-21% -$328K ﹤0.01% 3427
2021
Q1
$1.6M Buy
31,804
+6,052
+24% +$323K ﹤0.01% 3192
2020
Q4
$1.34M Sell
25,752
-10,688
-29% -$511K ﹤0.01% 3268
2020
Q3
$1.58M Buy
36,440
+8,195
+29% +$359K ﹤0.01% 2889
2020
Q2
$1.21M Sell
28,245
-2,176
-7% -$89.9K ﹤0.01% 3017
2020
Q1
$1.1M Buy
30,421
+12,001
+65% +$511K ﹤0.01% 2955
2019
Q4
$841K Sell
18,420
-14,271
-44% -$566K ﹤0.01% 3584
2019
Q3
$1.16M Buy
32,691
+3,240
+11% +$120K ﹤0.01% 3231
2019
Q2
$1.17M Buy
29,451
+11,830
+67% +$465K ﹤0.01% 3180
2019
Q1
$732K Sell
17,621
-39,862
-69% -$1.62M ﹤0.01% 3440
2018
Q4
$2.1M Buy
57,483
+36,466
+174% +$1.56M ﹤0.01% 2604
2018
Q3
$1.02M Buy
21,017
+3,874
+23% +$184K ﹤0.01% 3343
2018
Q2
$738K Sell
17,143
-614
-3% -$25.8K ﹤0.01% 3472
2018
Q1
$742K Sell
17,757
-22,334
-56% -$973K ﹤0.01% 3394
2017
Q4
$1.74M Buy
40,091
+9,341
+30% +$397K ﹤0.01% 2842
2017
Q3
$1.31M Buy
30,750
+10,869
+55% +$461K ﹤0.01% 3003
2017
Q2
$856K Sell
19,881
-20,211
-50% -$852K ﹤0.01% 3228
2017
Q1
$1.68M Sell
40,092
-9,738
-20% -$397K ﹤0.01% 2676
2016
Q4
$1.95M Buy
49,830
+42,059
+541% +$1.71M ﹤0.01% 2612
2016
Q3
$344K Buy
7,771
+1,353
+21% +$61.4K ﹤0.01% 4032
2016
Q2
$268K Sell
6,418
-3,597
-36% -$152K ﹤0.01% 4198
2016
Q1
$403K Buy
10,015
+2,704
+37% +$115K ﹤0.01% 3832
2015
Q4
$375K Sell
7,311
-7,358
-50% -$375K ﹤0.01% 4037
2015
Q3
$688K Sell
14,669
-21,999
-60% -$1.33M ﹤0.01% 3198
2015
Q2
$2.29M Sell
36,668
-24,600
-40% -$1.53M ﹤0.01% 2215
2015
Q1
$3.78M Buy
61,268
+7,784
+15% +$462K ﹤0.01% 1786
2014
Q4
$2.89M Buy
53,484
+6,488
+14% +$354K ﹤0.01% 2050
2014
Q3
$2.49M Sell
46,996
-3,962
-8% -$201K ﹤0.01% 2142
2014
Q2
$2.65M Sell
50,958
-7,008
-12% -$338K ﹤0.01% 2087
2014
Q1
$2.71M Sell
57,966
-7,712
-12% -$364K ﹤0.01% 2026
2013
Q4
$2.89M Sell
65,678
-28,938
-31% -$1.2M ﹤0.01% 2016
2013
Q3
$3.64M Buy
94,616
+78,450
+485% +$2.97M ﹤0.01% 1788
2013
Q2
$570K Buy
+16,166
New +$546K ﹤0.01% 3039

Other funds holding XPH